ADAP - Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) - Rantaian Opsyen

Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
US ˙ NasdaqCM ˙ US00653A1079

Tamat tempoh
Calls untuk tarikh pasaran September 05, 2025
Kontrak Strike Bida Tawar Terakhir Volum OI IV Delta Gamma Theta Vega Rho
ADAP20250919C00000500 0.50 0.00 0.05 0.00 0 1,126 0.00% 0.00 0.00 0.00 0.00 0.00
ADAP20250919C00001000 1.00 0.00 0.05 0.00 0 25 0.00% 0.00 0.00 0.00 0.00 0.00
ADAP20250919C00001500 1.50 0.00 0.90 0.00 0 65 0.00% 0.00 0.00 0.00 0.00 0.00
ADAP20250919C00002000 2.00 0.00 1.00 0.00 0 10 0.00% 0.00 0.00 0.00 0.00 0.00
ADAP20250919C00002500 2.50 0.00 0.05 0.01 5 77 0.00% 0.00 0.00 0.00 0.00 0.00
ADAP20250919C00005000 5.00 0.00 0.05 0.00 0 112 0.00% 0.00 0.00 0.00 0.00 0.00
ADAP20250919C00007500 7.50 0.00 0.05 0.00 0 65 0.00% 0.00 0.00 0.00 0.00 0.00
Puts untuk tarikh pasaran September 05, 2025
Kontrak Strike Bida Tawar Terakhir Volum OI IV Delta Gamma Theta Vega Rho
ADAP20250919P00000500 0.50 0.00 0.50 0.00 0 21 0.00% 0.00 0.00 0.00 0.00 0.00
ADAP20250919P00001000 1.00 0.85 1.00 0.00 0 173 0.00% 0.00 0.00 0.00 0.00 0.00
ADAP20250919P00001500 1.50 0.55 1.50 0.00 0 169 0.00% 0.00 0.00 0.00 0.00 0.00
ADAP20250919P00002000 2.00 1.05 2.00 0.00 0 166 0.00% 0.00 0.00 0.00 0.00 0.00
ADAP20250919P00002500 2.50 1.15 2.50 0.00 0 66 0.00% 0.00 0.00 0.00 0.00 0.00
ADAP20250919P00005000 5.00 3.60 5.00 0.00 0 26 0.00% 0.00 0.00 0.00 0.00 0.00
ADAP20250919P00007500 7.50 6.10 7.50 0.00 0 20 0.00% 0.00 0.00 0.00 0.00 0.00
Other Listings
DE:473A €0.04
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista